Cochlear Limited (ASX:COH)
Australia · Delayed Price · Currency is AUD 279.06
-1.36 (-0.48%)
At close: Nov 28, 2025
Cochlear Market Cap
Cochlear has a market cap or net worth of 18.25 billion as of November 28, 2025. Its market cap has decreased by -4.86% in one year.
Market Cap
18.25B
Enterprise Value
18.21B
Revenue
2.34B
Ranking
n/a
PE Ratio
47.07
Stock Price
279.06
Market Cap Chart
Since December 12, 1995, Cochlear's market cap has increased from 44.18M to 18.25B, an increase of 41,209.20%. That is a compound annual growth rate of 22.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 18.25B | -3.78% |
| Dec 31, 2024 | 18.97B | -3.04% |
| Dec 29, 2023 | 19.56B | 45.68% |
| Dec 30, 2022 | 13.43B | -5.54% |
| Dec 31, 2021 | 14.22B | 14.41% |
| Dec 31, 2020 | 12.43B | -4.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 89.97B |
| Pro Medicus | 27.85B |
| Sonic Healthcare | 11.53B |
| Ramsay Health Care | 8.46B |
| Ansell | 5.37B |
| Telix Pharmaceuticals | 5.16B |
| Mesoblast | 3.48B |
| Neuren Pharmaceuticals | 2.48B |